Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa

Current Medical Research and Opinion

Volumn 20, Issue 8, 2004, Pages 1175-1183

  Roland, Peter S ^a   Pien, Francis D ^b   Schultz, Craig C ^c   Henry, Dan C ^d   Conroy, Peter J ^e   Wall, G Michael ^e   Garadi, Rekha ^e   Dupre, Sheryl J ^e   Potts, Susan L ^e   Hogg, L Gail ^e   Stroman, David W ^e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b STRAUB CLINIC AND HOSPITAL   (United States)

^c Med Associates Clinic   (United States)

^d Foothill Family Clinic   (United States)

^e ALCON RESEARCH LTD   (United States)

Author keywords

Fluoroquinolone; Otitis externa; Ototopical anti infective; Ototoxicity

Indexed keywords

CIPRODEX; CIPROFLOXACIN; CORTISPORIN; DEXAMETHASONE;

ADOLESCENT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EARDRUM; EDEMA; ERYTHEMA; EXTERNAL OTITIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OTALGIA; OTITIS; OUTCOMES RESEARCH; PARESTHESIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SUPERINFECTION; TREATMENT OUTCOME;

EID: 4344646343     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125004312     Document Type: Article

References (26)

1. Hirsch BE. Diseases of the external ear. In: Bluestone CD, Stool SE, Kenna MA, editors. Pediatric otolaryngology, Vol. 1, 3rd ed. Philadelphia: W.B. Saunders, 1996. pp. 379-81
2. Stroman DW, Roland PS, Dohar J, Burt W. Microbiology of normal external auditory canal. Laryngoscope 2001;111:2054-2059
3. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope 2002;112:1166-1177
4. Gydé MC, Norris D, Kavalec EC. The weeping ear: clinical reevaluation of treatment. J Int Med Res 1982;10:333-40
5. Wadsten CJ, Bertilsson CA, Sieradzki, H, Edstom S. A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Arch Otorhinolaryngol 1985;242:135-9
6. Wiedemann B, Grimm H. Susceptibility to antibiotics: species incidence and trends. In: Lorian V, editor. Antibiotics in laboratory medicine, 4th ed. Baltimore: Williams and Wilkins; 1996. pp. 900-1168
7. Altuntas A, Aslan A, Eren N, Unal A, Nalca Y. Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin. Eur Arch Otorhinolarygol 1996;253:364-6
8. Rodriguez JAG, Sanchez JEG, Garcia MIG, Sanchez EG, Bellido JLM, Macias AR. Efficacy of topical ciprofloxacin in the treatment of ear infections in adults. J Antimicrob Chemother 1993;31:452-3
9. Rodriguez VP, Pinero MJS, Ramos AJ, Villarejo PL. Efficacy of topical ciprofloxacin in the treatment of chronic otorrhea. Acta Otorrinolaringol Esp 1995;46:15-18
10. Claes J, Govaerts PJ, Van de Heyning PH, Peeters S. Lack of ciprofloxacin ototoxicity after repeated ototopical application. Antimicrob Agents Chemother 1991;35:1014-6
11. Brownlee RE, Hulka GF, Prazma J, Pillsbury HC. Ciprofloxacin: use as a topical otic preparation. Arch Otolaryngol Head Neck Surg 1992;118:392-6
12. Esposito S, D'Errico G, Montanaro C. Topical and oral treatment of chronic otitis media with ciprofloxacin. Arch Otalaryngol Head Neck Surg 1990;116:557-9
13. Force RW, Hart MC, Plummer SA, Powell DA, Nahata MC. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otalaryngol Head Neck Surg 1995;121:880-4
14. Lorente J, Sabater F, Maristany M, et al. Multicentre study comparing the efficacy and tolerance of topical ciprofloxacin (0.3%) versus topical gentamicin (0.3%) in the treatment of simple, non-cholesteatomatous chronic otitis media in the suppurative phase. An Otorrinolaringol Ibero Am 1995;22:521-33
15. Tutkun A, Ozagar A, Koc A, Batman C, Uneri C, Sehitoglu MA. Treatment of chronic ear disease: topical ciprofloxacin vs topical gentamicin. Arch Otalaryngol Head Neck Surg 1995;121:1414-16
16. Ozagar A, Koc A, Ciprut A, Tutkun A, Akdas F, Sehitoglu MA. Effects of topical otic preparations on hearing in chronic otitis media. Otolaryngol Head Neck Surg 1997;117:405-8
17. Piccirillo JF, Parnes SM. Ciprofloxacin for the treatment of chronic ear disease. Laryngoscope 1989;99:510-3
18. Balkany TJ, Bradford DR: Infections of the external ear. In: Cummings CW, editor. Cummings Otolaryngology Head and Neck Surgery. MO, Mosby, 1997. pp. 2979-2986
19. Goldenberg D, Golz A, Netzer A, Joachims HZ. The use of otic powder in the treatment of acute external otitis. Am J Otolaryngol 2002;23:142-147
20. Ganz, H. Local Antibiotic treatment of bacterial infections in the ear. HNO 1989;37:386-8
21. Arnes E, Dibb WL. Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment. Curr Med Res Opin 1993;13:182-6
22. De Schepper S, Schmelzer B. Local treatment of external otitis and otitis media: role of the quinolones. Acta Otorhinolaryngol Belg 1994;48:67-70
23. Pistorius B, Westberry K, Drehobl M, et al. Otitis Externa Study Group. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externa. Infectious Diseases in Clinical Practice 1999;8:387-95
24. Kruse W, Eggert-Kruse W, Rampmaier J, Runnebaum B, Weber E. Dosage frequency and drug-compliance behaviour - a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 1991;41:589-92
25. Brun J. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study. J Int Med Res 1994;22:266-72
26. Roland PS, Stroman DW. Topical therapy treatment failures in children with acute otitis media with otorrhea through a tympanostomy tube. The International Symposium on Recent Advances in Otitis Media; 2003 Jun 3-7; Ft. Lauderdale, FL, Poster No. P9: p. 252